← Open Payments lookup

CHIKA UGWU: Open Payments

NPI 1760113195 · AUBURN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,514 in 70 payments from 11 companies in 2025. Trend: 2023 $143 · 2024 $326 · 2025 $1,514

Food & beverage: $1,514
CompanyPaymentsAmount
ABBVIE INC.35$642
Vanda Pharmaceuticals Inc.5$183
Janssen Pharmaceuticals, Inc9$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$138
E.R. Squibb & Sons, L.L.C.6$113
Alkermes, Inc.4$93
Neurocrine BioSciences, Inc.4$77
Otsuka America Pharmaceutical, Inc.2$50
Lundbeck LLC1$22
Teva Pharmaceuticals USA, Inc.1$15

Products named: VRAYLAR, INVEGA SUSTENNA, FANAPT, CAPLYTA, COBENFY, INGREZZA, VIVITROL, REXULTI.

Industry payments across CA — which companies pay providers there.